Ross JS - Search Results

1

Ensuring Public Trust in an Empowered FDA.

Ross JS, Berg KM, Ramachandran R. Ross JS, et al. N Engl J Med. 2023 Apr 6;388(14):1249-1251. doi: 10.1056/NEJMp2300438. Epub 2023 Apr 1. N Engl J Med. 2023. PMID: 37017494 No abstract available.

2

The updated AMSA scorecard of conflict-of-interest policies: a survey of U.S. medical schools.

Carlat DJ, Fagrelius T, Ramachandran R, Ross JS, Bergh S. Carlat DJ, et al. Among authors: ross js. BMC Med Educ. 2016 Aug 12;16(1):202. doi: 10.1186/s12909-016-0725-y. BMC Med Educ. 2016. PMID: 27519253 Free PMC article.

3

Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults.

Sobieraj DM, Martinez BK, Hernandez AV, Coleman CI, Ross JS, Berg KM, Steffens DC, Baker WL. Sobieraj DM, et al. Among authors: ross js. J Am Geriatr Soc. 2019 Aug;67(8):1571-1581. doi: 10.1111/jgs.15966. Epub 2019 May 29. J Am Geriatr Soc. 2019. PMID: 31140587

4

Modernizing the FDA's 510(k) Pathway.

Rathi VK, Ross JS. Rathi VK, et al. Among authors: ross js. N Engl J Med. 2019 Nov 14;381(20):1891-1893. doi: 10.1056/NEJMp1908654. Epub 2019 Oct 23. N Engl J Med. 2019. PMID: 31644865 No abstract available.

5

Future of covid-19 vaccine pricing: lessons from influenza.

Ramachandran R, Dhodapkar M, Ross JS, Schwartz JL. Ramachandran R, et al. Among authors: ross js. BMJ. 2021 Jun 22;373:n1467. doi: 10.1136/bmj.n1467. BMJ. 2021. PMID: 34158283 No abstract available.

6

Early experience with the FDA's regulatory review of novel gene therapies.

Puthumana J, Egilman AC, Ramachandran R, Naushad N, Shah N, Ross J. Puthumana J, et al. BMJ Evid Based Med. 2022 Aug;27(4):195-198. doi: 10.1136/bmjebm-2021-111720. Epub 2021 Oct 11. BMJ Evid Based Med. 2022. PMID: 34635478 No abstract available.

7

Comparison of Duration of Postapproval vs Pivotal Trials for Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval, 2009-2018.

Wallach JD, Ramachandran R, Bruckner T, Ross JS. Wallach JD, et al. Among authors: ross js. JAMA Netw Open. 2021 Nov 1;4(11):e2133601. doi: 10.1001/jamanetworkopen.2021.33601. JAMA Netw Open. 2021. PMID: 34751764 Free PMC article.

8

Strengthening the FDA's Enforcement of ClinicalTrials.gov Reporting Requirements.

Ramachandran R, Morten CJ, Ross JS. Ramachandran R, et al. Among authors: ross js. JAMA. 2021 Dec 7;326(21):2131-2132. doi: 10.1001/jama.2021.19773. JAMA. 2021. PMID: 34766971 No abstract available.

9

Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials.

Ramachandran R, Ross JS, Miller JE. Ramachandran R, et al. Among authors: ross js. JAMA Netw Open. 2021 Nov 1;4(11):e2134233. doi: 10.1001/jamanetworkopen.2021.34233. JAMA Netw Open. 2021. PMID: 34792596 Free PMC article.

10

Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.

Zhou T, Liu P, Dhruva SS, Shah ND, Ramachandran R, Berg KM, Ross JS. Zhou T, et al. Among authors: ross js. JAMA Intern Med. 2022 Feb 1;182(2):185-195. doi: 10.1001/jamainternmed.2021.7457. JAMA Intern Med. 2022. PMID: 34982097 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,633 results

Search Page